Prospective cohort study observes progressive carotid thickening linked to visfatin and YKL-40 in peritoneal dialysis patients, highlighting potential inflammatory pathways in vascular remodeling.
BACKGROUND: Cardiovascular disease is the leading cause of mortality in peritoneal dialysis (PD) patients. We investigated the cross-sectional and longitudinal associations of visfatin, YKL-40, and adiponectin with carotid intima-media thickness (CIMT) over 12 months. METHODS: In this 12-month prospective cohort study, 30 maintenance PD patients underwent serial serum biomarker assessment and bilateral CIMT measurement. Associations were evaluated using paired comparisons and correlation analyses. RESULTS: Both right and left CIMT increased significantly over 12 months (p < 0.01). Visfatin increased, adiponectin decreased (both p < 0.001), whereas YKL-40 remained stable. Visfatin and YKL-40 showed significant positive correlations with CIMT, while adiponectin showed negative correlations. A strong positive visfatin-YKL-40 inter-correlation was observed (r = 0.659, p < 0.001), representing a novel finding, to our knowledge, in a dialysis population. CONCLUSIONS: CIMT increased significantly over 12 months in PD patients. Visfatin and YKL-40 showed consistent positive cross-sectional associations with CIMT, whereas adiponectin showed inverse associations and declined over time. Longitudinal biomarker-CIMT associations were limited, with baseline YKL-40 being the only biomarker associated with right-sided ΔCIMT. These exploratory findings suggest potential inflammatory pathways involved in vascular remodeling in PD and warrant validation in larger prospective studies.
No takes yet. Share an insight, caveat, or question.
KINDAN et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: